Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers

David F Grabski, Aakrosh Ratan, Laurie R Gray, Stefan Bekiranov, David Rekosh, Marie-Louise Hammarskjold, Sara K Rasmussen
doi: https://doi.org/10.1101/2020.02.28.20026260

Article usage

Article usage: March 2020 to June 2025

AbstractFullPdf
Mar 2020350087
Apr 2020110064
May 202085017
Jun 20203407
Jul 20204808
Aug 202035016
Sep 202023022
Oct 20201307
Nov 202018020
Dec 202014011
Jan 20212426
Feb 202168010
Mar 202167518
Apr 202196224
May 202176427
Jun 202168418
Jul 202127116
Aug 202116714
Sep 202120028
Oct 202117044
Nov 202127947
Dec 202126321
Jan 202222614
Feb 202215211
Mar 202212023
Apr 202214314
May 202212423
Jun 202211415
Jul 20221135
Aug 202216115
Sep 202226018
Oct 202225318
Nov 202211023
Dec 20221319
Jan 202318311
Feb 202312318
Mar 20238312
Apr 202318312
May 20238111
Jun 20235612
Jul 2023208
Aug 2023141310
Sep 20231048
Oct 2023906
Nov 20231176
Dec 20231664
Jan 2024736
Feb 20245314
Mar 202416419
Apr 20243108
May 2024218
Jun 2024936
Jul 20245912
Aug 20245212
Sep 202413616
Oct 20241049
Nov 20248510
Dec 2024418
Jan 2025938
Feb 2025739
Mar 2025162119
Apr 2025111915
May 202552118
Jun 2025417
Back to top
Posted March 03, 2020.
Download PDF
Data/Code
Email
Upregulation of Human Endogenous Retrovirus-K (HML-2) mRNAs in hepatoblastoma: Identification of potential new immunotherapeutic targets and biomarkers
David F Grabski, Aakrosh Ratan, Laurie R Gray, Stefan Bekiranov, David Rekosh, Marie-Louise Hammarskjold, Sara K Rasmussen
medRxiv 2020.02.28.20026260; doi: https://doi.org/10.1101/2020.02.28.20026260
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area